APEN - Apollo Endosurgery, Inc.

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow
Annual
Subscribe to Premium to download historical data

Income Statement

All numbers in thousands
Breakdown
ttm
12/31/2019
12/31/2018
12/31/2017
12/31/2016
Total Revenue
50,713
50,713
60,854
64,310
64,868
Cost of Revenue
25,038
25,038
27,660
24,578
25,255
Gross Profit
25,675
25,675
33,194
39,732
39,613
Operating Expenses
Research Development
10,384
10,384
12,176
8,299
7,805
Selling General and Administrative
42,318
42,318
46,267
46,632
45,376
Total Operating Expenses
54,797
54,797
65,517
62,171
60,374
Operating Income or Loss
-29,122
-29,122
-32,323
-22,439
-20,761
Total Other Income/Expenses Net
6,017
6,017
-9,210
-41
-1,851
Income Before Tax
-27,157
-27,157
-45,596
-26,988
-40,780
Income Tax Expense
275
275
191
304
387
Income from Continuing Operations
-27,432
-27,432
-45,787
-27,292
-41,167
Net Income
-27,432
-27,432
-45,787
-27,292
-41,167
Net Income available to common shareholders
-27,432
-27,432
-45,787
-27,292
-41,167
Basic EPS
-
-
-2.31
-2.01
-105.69
Diluted EPS
-
-
-2.31
-2.01
-105.69
Basic Average Shares
-
-
19,790
13,566
389.501
Diluted Average Shares
-
-
19,790
13,566
389.501
EBITDA
-
-25,062
-23,031
-12,722
-11,669